Skip to content

Author

Millie Tiffani León Jiménez

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Impact of Mavacamten in the treatment of hypertrophic cardiomyopathy

Introduction: Hypertrophic cardiomyopathy is a genetic disease characterized by left ventricular hypertrophy and, in some patients, left ventricular outflow tract obstruction. Mavacamten is a primary cardiac myosin inhibitor that reduces hypercontractility, decreases actin-myosin cross-bridge formation, and promotes mo...

Karen Jessica Pilatasig Bazurto, Millie Tiffani León Jiménez, Edison Humberto Ruiz Intriago et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.